Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ENLV | US
-0.06
-3.55%
Healthcare
Biotechnology
30/06/2024
17/10/2024
1.63
1.70
1.71
1.60
Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial as well as in preclinical trial to treat solid tumors. The company has a collaboration agreement with BeiGene to evaluate the safety and efficacy of Allocetra in combination with tislelizumab an anti-PD-1 immune checkpoint inhibitor for the treatment of patients with advanced-stage solid tumors. Enlivex Therapeutics Ltd. is headquartered in Ness Ziona Israel.
View LessPositive Momentum
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Weakness based on declining price with high volume
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
75.0%1 month
64.6%3 months
68.3%6 months
70.0%-
-
1.12
0.03
0.03
-1.49
-
-
-17.89M
34.89M
34.89M
-
-
-
-
-61.17
0.70
0.52
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.37
Range1M
0.39
Range3M
0.61
Rel. volume
1.42
Price X volume
279.06K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Equillium Inc | EQ | Biotechnology | 1.08 | 38.26M | -1.82% | n/a | 2.71% |
Common Stock | TARA | Biotechnology | 1.85 | 38.17M | -0.54% | n/a | 5.41% |
PASSAGE BIO INC. | PASG | Biotechnology | 0.596 | 37.86M | 0.86% | n/a | 28.88% |
BioLineRx Ltd | BLRX | Biotechnology | 0.462 | 36.93M | -1.70% | n/a | 223.55% |
Lantern Pharma Inc. | LTRN | Biotechnology | 3.39 | 36.49M | -3.14% | n/a | 0.71% |
QNCX | QNCX | Biotechnology | 0.7929 | 34.31M | -3.19% | n/a | 30.62% |
OKYO Pharma Limited | OKYO | Biotechnology | 1.01 | 34.17M | -3.81% | n/a | -107.88% |
OCUP | OCUP | Biotechnology | 1.27 | 33.54M | -0.78% | n/a | 0.00% |
Moolec Science SA Ordinary Shares | MLEC | Biotechnology | 0.89 | 33.34M | -3.26% | n/a | 209.19% |
Dyadic International Inc | DYAI | Biotechnology | 1.13 | 33.31M | -2.59% | n/a | 175.64% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.6 | 19.19M | 0.80% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 0.98 | 17.70M | -3.92% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -1.49 | 0.53 | Cheaper |
Ent. to Revenue | - | 4,005.99 | - |
PE Ratio | - | 40.42 | - |
Price to Book | 1.12 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 68.33 | 72.92 | Par |
Debt to Equity | 0.03 | -1.24 | Expensive |
Debt to Assets | 0.03 | 0.25 | Cheaper |
Market Cap | 34.89M | 3.78B | Emerging |